AI Article Synopsis

  • Over 80 different mutations in the SOD1 protein are linked to familial amyotrophic lateral sclerosis (fALS), causing the protein to misfold and aggregate.
  • The study focused on mutating specific Glu residues at positions 40 and 133 that help stabilize the protein's structure, with the aim to understand how these changes contribute to misfolding and aggregation.
  • Using a fluorescent fusion assay, researchers found that certain mutations lead to aggregation through the introduction of steric strain in the 3D structure of the protein.

Article Abstract

Mutations in more than 80 different positions in superoxide dismutase 1 (SOD1) have been associated with amyotrophic lateral sclerosis (fALS). There is substantial evidence that a common consequence of these mutations is to induce the protein to misfold and aggregate. How these mutations perturb native structure to heighten the propensity to misfold and aggregate is unclear. In the present study, we have mutagenized Glu residues at positions 40 and 133 that are involved in stabilizing the β-barrel structure of the native protein and a critical Zn binding domain, respectively, to examine how specific mutations may cause SOD1 misfolding and aggregation. Mutations associated with ALS as well as experimental mutations were introduced into these positions. We used an assay in which mutant SOD1 was fused to yellow fluorescent protein (SOD1:YFP) to visualize the formation of cytosolic inclusions by mutant SOD1. We then used existing structural data on SOD1, to predict how different mutations might alter local 3D conformation. Our findings reveal an association between mutant SOD1 aggregation and amino acid substitutions that are predicted to introduce steric strain, sometimes subtly, in the 3D conformation of the peptide backbone.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404617PMC
http://dx.doi.org/10.1534/g3.118.200787DOI Listing

Publication Analysis

Top Keywords

mutant sod1
12
experimental mutations
8
superoxide dismutase
8
amyotrophic lateral
8
lateral sclerosis
8
misfold aggregate
8
mutations
7
sod1
6
mutations superoxide
4
dismutase provide
4

Similar Publications

Investigating the impact of SOD1 mutations on amyotrophic lateral sclerosis progression and potential drug repurposing through analysis.

J Biomol Struct Dyn

December 2024

Department of Medical Laboratory Technology, Faculty of Medical Applied Science, Northern Border University, Arar, Saudi Arabia.

Superoxide dismutase 1 (SOD1) is a vital enzyme responsible for attenuating oxidative stress through its ability to facilitate the dismutation of the superoxide radical into oxygen and hydrogen peroxide. The progressive loss of motor neurons characterize amyotrophic lateral sclerosis (ALS), a crippling neurodegenerative disease that is caused by mutations in the SOD1 gene. In this study, mutational analysis was performed to study the various mutations, the pathogenicity and stability ΔΔG (binding free energy) of the variant of SOD1.

View Article and Find Full Text PDF

Neurodegenerative disorders are characterized by a progressive decline of specific neuronal populations in the brain and spinal cord, typically containing aggregates of one or more proteins. They can result in behavioral alterations, memory loss and a decline in cognitive and motor abilities. Various pathways and mechanisms have been outlined for the potential treatment of these diseases, where redox regulation is considered as one of the most common druggable targets.

View Article and Find Full Text PDF

Disturbances in metal ion homeostasis associated with amyotrophic lateral sclerosis (ALS) have been described for several years, but the exact mechanism of involvement is not well understood. To elucidate the role of metalation in superoxide dismutase (SOD1) misfolding and aggregation, we comprehensively characterized the structural features (apo/holo forms) of WT-SOD1 and P66R mutant in loop IV. Using computational and experimental methodologies, we assessed the physicochemical properties of these variants and their correlation with protein aggregation at the molecular level.

View Article and Find Full Text PDF

Human VCP mutant ALS/FTD microglia display immune and lysosomal phenotypes independently of GPNMB.

Mol Neurodegener

November 2024

Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.

Article Synopsis
  • Microglia, the brain's immune cells, are vital for neuron health but may worsen conditions like ALS and FTD, and their exact role in these diseases is still unclear.
  • Researchers created specialized cultures of microglia from human stem cells with VCP mutations to study their behavior and effects on nearby nerve cells and supportive cells, using advanced techniques like RNA sequencing and proteomics.
  • The studies revealed that VCP mutant microglia show immune system and lysosomal issues, react differently to inflammation compared to healthy microglia, and can influence motor neurons and astrocytes through secreted factors, even though certain genetic factors didn't fully address their dysfunction.
View Article and Find Full Text PDF

Upregulated miR-10b-5p as a potential miRNA signature in amyotrophic lateral sclerosis patients.

Front Cell Neurosci

November 2024

Translational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, Rostock, Germany.

Amyotrophic lateral sclerosis (ALS) is a fatal, adult-onset disease marked by a progressive degeneration of motor neurons (MNs) present in the spinal cord, brain stem and motor cortex. Death in most patients usually occurs within 2-4 years after symptoms onset. Despite promising progress in delineating underlying mechanisms, such as disturbed proteostasis, DNA/RNA metabolism, splicing or proper nucleocytoplasmic shuttling, there are no effective therapies for the vast majority of cases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!